TCL Archive Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology April 5, 2002
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive NCI Receives 165 SBIR Grant Applications; Combines With Solid Contracts, No More Fiascos Are Expected June 14, 1985